Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
- Author
- DE SOUZA MALASPINA, Tatiana Salles1 ; GASPAROTO, Thaís Helena1 ; NOGUEIRA COSTA, Maria Renata Sales3 ; DE MELO, Edgard Franco3 ; IKOMA, Maura Rosane Valerio4 ; DAMANTE, José Humberto2 ; CAVASSANI, Karen Angelica6 ; POMPERMAIER GARLET, Gustavo1 ; SANTANA DA SILVA, João5 ; CAMPANELLI, Ana Paula1
[1] Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Octavio Pinheiro Brisolla, 9-75, Bauru, SP CEP 17012-901, Brazil
[2] Department of Stomatology, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
[3] Dermatology and Research Division, Institute Lauro de Souza Lima, Bauru, SP, Brazil
[4] Amaral Carvalho Hospital, Jaú, SP, Brazil
[5] Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
[6] Department of Pathology, Medical School, University of Michigan, Ann Arbor, MI, United States - Source
Cancer immunology and immunotherapy. 2011, Vol 60, Num 7, pp 965-974, 10 p ; ref : 48 ref
- CODEN
- CIIMDN
- ISSN
- 0340-7004
- Scientific domain
- Biochemistry, molecular biology, biophysics; Medical oncology; Immunology, immunopathology, allergology
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Actinic cheilitis Oral squamous cell carcinoma PD-1
- Keyword (fr)
- Cancer de la cavité buccale Carcinome épidermoïde de la cavité buccale Cheilite actinique Expression génique Homme Immunothérapie Ligand Lèvre Malade Mort Mortalité Traitement Protéine CAM L1 Protéine PD 1 Cancer Pathologie de la cavité buccale Pathologie de la peau Photosensibilité Stomatologie Tumeur maligne
- Keyword (en)
- Oral cancer Oral squamous cell carcinoma Actinic cheilitis Gene expression Human Immunotherapy Ligand Lip Patient Death Mortality Treatment Cell adhesion molecule L1 Programmed cell death protein 1 Cancer Oral cavity disease Skin disease Photosensitivity Stomatology Malignant tumor
- Keyword (es)
- Cáncer de cavidad bucal Carcinoma epidermoide de cavidad bucal Queilitis actínica Expresión genética Hombre Inmunoterapia Ligando Labio Enfermo Muerte Mortalidad Tratamiento Proteína CAM L1 Proteína PD 1 Cáncer Cavidad bucal patología Piel patología Fotosensibilidad Estomatología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08J Skin involvement in other diseases. Miscellaneous. General aspects
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10B Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology / 002B10B01 Tumors
- Discipline
- Dermatology Otorhinolaryngology. Stomatology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24322696
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00262-011-1007-5 
https://dx.doi.org/10.1007/s00262-011-1007-5
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"965\";s:8:\"\u0000*\u0000epage\";s:3:\"974\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"DE SOUZA MALASPINA\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Tatiana Salles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:24:\"GASPAROTO, Tha\u00eds Helena\";i:1;s:34:\"NOGUEIRA COSTA, Maria Renata Sales\";i:2;s:22:\"DE MELO, Edgard Franco\";i:3;s:27:\"IKOMA, Maura Rosane Valerio\";i:4;s:23:\"DAMANTE, Jos\u00e9 Humberto\";i:5;s:25:\"CAVASSANI, Karen Angelica\";i:6;s:27:\"POMPERMAIER GARLET, Gustavo\";i:7;s:23:\"SANTANA DA SILVA, Jo\u00e3o\";i:8;s:21:\"CAMPANELLI, Ana Paula\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"965\";s:8:\"\u0000*\u0000epage\";s:3:\"974\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"DE SOUZA MALASPINA\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Tatiana Salles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:24:\"GASPAROTO, Tha\u00eds Helena\";i:1;s:34:\"NOGUEIRA COSTA, Maria Renata Sales\";i:2;s:22:\"DE MELO, Edgard Franco\";i:3;s:27:\"IKOMA, Maura Rosane Valerio\";i:4;s:23:\"DAMANTE, Jos\u00e9 Humberto\";i:5;s:25:\"CAVASSANI, Karen Angelica\";i:6;s:27:\"POMPERMAIER GARLET, Gustavo\";i:7;s:23:\"SANTANA DA SILVA, Jo\u00e3o\";i:8;s:21:\"CAMPANELLI, Ana Paula\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"965\";s:8:\"\u0000*\u0000epage\";s:3:\"974\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"DE SOUZA MALASPINA\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Tatiana Salles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:24:\"GASPAROTO, Tha\u00eds Helena\";i:1;s:34:\"NOGUEIRA COSTA, Maria Renata Sales\";i:2;s:22:\"DE MELO, Edgard Franco\";i:3;s:27:\"IKOMA, Maura Rosane Valerio\";i:4;s:23:\"DAMANTE, Jos\u00e9 Humberto\";i:5;s:25:\"CAVASSANI, Karen Angelica\";i:6;s:27:\"POMPERMAIER GARLET, Gustavo\";i:7;s:23:\"SANTANA DA SILVA, Jo\u00e3o\";i:8;s:21:\"CAMPANELLI, Ana Paula\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"965\";s:8:\"\u0000*\u0000epage\";s:3:\"974\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"DE SOUZA MALASPINA\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Tatiana Salles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:24:\"GASPAROTO, Tha\u00eds Helena\";i:1;s:34:\"NOGUEIRA COSTA, Maria Renata Sales\";i:2;s:22:\"DE MELO, Edgard Franco\";i:3;s:27:\"IKOMA, Maura Rosane Valerio\";i:4;s:23:\"DAMANTE, Jos\u00e9 Humberto\";i:5;s:25:\"CAVASSANI, Karen Angelica\";i:6;s:27:\"POMPERMAIER GARLET, Gustavo\";i:7;s:23:\"SANTANA DA SILVA, Jo\u00e3o\";i:8;s:21:\"CAMPANELLI, Ana Paula\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00262-011-1007-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Cancer immunology and immunotherapy\";s:9:\"\u0000*\u0000stitle\";s:26:\"Cancer immunol. immunother\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"965\";s:8:\"\u0000*\u0000epage\";s:3:\"974\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-7004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:18:\"DE SOUZA MALASPINA\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Tatiana Salles\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:24:\"GASPAROTO, Tha\u00eds Helena\";i:1;s:34:\"NOGUEIRA COSTA, Maria Renata Sales\";i:2;s:22:\"DE MELO, Edgard Franco\";i:3;s:27:\"IKOMA, Maura Rosane Valerio\";i:4;s:23:\"DAMANTE, Jos\u00e9 Humberto\";i:5;s:25:\"CAVASSANI, Karen Angelica\";i:6;s:27:\"POMPERMAIER GARLET, Gustavo\";i:7;s:23:\"SANTANA DA SILVA, Jo\u00e3o\";i:8;s:21:\"CAMPANELLI, Ana Paula\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIIMDN\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
